共 50 条
- [21] Evaluation of Oncotype DX Recurrence Score as a prognostic factor in Japanese women with estrogen receptor-positive, node-negative primary Stage I or IIA breast cancer [J]. Journal of Cancer Research and Clinical Oncology, 2010, 136 : 939 - 944
- [26] Clinical utility of the 21-gene Oncotype DX® Recurrence Score® (RS) assay in hormone receptor-positive, HER2-negative breast cancer (BC) [J]. BREAST, 2017, 32 : S97 - S97
- [29] Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test in Node-Negative Early Breast Cancer [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2022, 14 : 619 - 633
- [30] Association Between Ki-67 Proliferative Index and Oncotype-Dx Recurrence Score in Hormone Receptor-Positive, HER2-Negative Early Breast Cancers. A Systematic Review of the Literature [J]. BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2024, 18